Search results
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 23 hours ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 21 hours agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 23 hours agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
KEYT 3 Santa Barbara· 4 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 4 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 23 hours agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 15 hours agoYounger children, adults 65 and older and immunocompromised...people may need multiple doses, the...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 4 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoEarlier in the year, one analyst called results from the cancer vaccine study "transformational."...